COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,317 Articles (22,772 medRxiv, 8,545 bioRxiv)

Most recent first Previous |  Page 1029: Articles 10281-10290  | Next

Protective effect of BNT162b2 vaccination on aerobic capacity following mild to moderate SARS-CoV-2 infection: a cross sectional study, Israel, March-December 2021
Blumberg, Y., Edelstein, M., Abu Jabal, K., Golan, R., Perets, Y., Saad, M., Levinas, T., Dabbah, S., Israeli, Z., Yacoubi, S., Abu Raya, A., Amital, A., Halabi, M.
10.1101/2021.12.30.21268538 — Posted: 2022-01-01
Vaccine Effectiveness against COVID-19 among Symptomatic Persons Aged >=12 Years with Reported Contact with COVID-19 Cases, February - September 2021
Chung, J., Kim, S., Belongia, E. A., McLean, H. Q., King, J. P., Nowalk, M. P., Zimmerman, R. K., Moehling Geffel, K., Martin, E. T., Monto, A., Lamerato, L. E., Gaglani, M., Hoffman, E., Volz, M., Jackson, M. L., Jackson, L. A., Patel, M. M., Flannery, B.
10.1101/2021.12.30.21267928 — Posted: 2022-01-01
Preferential expansion of cross-reactive pre-existing switched memory B cells that recognize the SARS-CoV-2 Omicron variant Spike protein
Perugino, C. A., Liu, H., Feldman, J., Hauser, B. M., Jacob-Dolan, C., Nathan, A., Zhou, Z., Kaseke, C., Tano-Menka, R., Getz, M. A., Sanjobe, F., Berrios, C., Ofoman, O., Lemieux, J., Goldberg, M. B. A., Nundel, K., Marshak-Rothstein, A., Iafrate, J., Gaiha, G., Charles, R., Balazs, A. B., Naranbhai, V., Schmidt, A. G., Pillai, S.
10.1101/2021.12.30.21268554 — Posted: 2022-01-01
Waning of SARS-CoV-2 Antibody levels response to inactivated cellular vaccine over 6 months among healthcare workers
Taminato, M., Chaves, A. P. C., Morais, R. B. d., Moreira, L. V. L., Conte, D. D., Faico-Filho, K. S., Gabrielloni, M. C., de Medeiros, E. A., Bellei, N.
10.1101/2021.12.30.21268532 — Posted: 2022-01-01
Antibody binding and ACE2 binding inhibition is significantly reduced for the Omicron variant compared to all other variants of concern
Junker, D., Becker, M., Wagner, T., Kaiser, P. D., Maier, S., Grimm, T. M., Griesbaum, J., Marsall, P., Gruber, J., Traenkle, B., Heinzel, C., Pinilla, Y. T., Held, J., Fendel, R., Kreidenweiss, A., Nelde, A., Maringer, Y., Schroeder, S., Walz, J. S., Althaus, K., Uzun, G., Mikus, M., Bakchoul, T., Schenke-Layland, K., Bunk, S., Haeberle, H., Bitzer, M., Goepel, S., Renk, H., Remppis, J., Engel, C., Franz, A. R., Harries, M., Kessel, B., Strengert, M., Krause, G., Zeck, A., Rothbauer, U., Dulovic, A., Schneiderhan-Marra, N.
10.1101/2021.12.30.21267519 — Posted: 2022-01-01
Predicting the impact of COVID-19 vaccination campaigns - a flexible age-dependent, spatially-stratified predictive model, accounting for multiple viral variants and vaccines
Schneider, K. A., Tsoungui Obama, H. C. J., Adil Mahmoud Yousif, N., Ngougoue Ngougoue, P. M.
10.1101/2021.12.29.21268526 — Posted: 2022-01-01
Global Perspective of COVID-19 Vaccine Nationalism
Basak, P., ABIR, T., Mamun, A. A., Zainol, N. R., Khanam, M., Haque, M. R., Milton, A. H., Agho, K. E.
10.1101/2021.12.31.21268580 — Posted: 2022-01-01
Effectiveness of COVID-19 vaccines against Omicron or Delta infection
Buchan, S. A., Chung, H., Brown, K. A., Austin, P. C., Fell, D. B., Gubbay, J., Nasreen, S., Schwartz, K. L., Sundaram, M. E., Tadrous, M., Wilson, K., Wilson, S. E., Kwong, J.
10.1101/2021.12.30.21268565 — Posted: 2022-01-01 Discussion: Onsite
Humoral immune responses against SARS-CoV-2 variants including omicron in solid organ transplant recipients after three doses of a COVID-19 mRNA vaccine
Saharia, K. K., Husson, J. S., Niederhaus, S. V., Iraguha, T., Avila, S. V., Yoo, Y. J., Hardy, N. M., Fan, X., Omili, D., Crane, A., Carrier, A., Xie, W. Y., Vander Mause, E., Hankey, K., Bauman, S., Lesho, P., Mannuel, H. D., Ahuja, A., Mathew, M., Avruch, J., Baddley, J., Goloubeva, O., Shetty, K., Dahiya, S., Rapoport, A. P., Luetkens, T., Atanackovic, D.
10.1101/2021.12.29.21268529 — Posted: 2022-01-01
Early signals of significantly increased vaccine breakthrough, decreased hospitalization rates, and less severe disease in patients with COVID-19 caused by the Omicron variant of SARS-CoV-2 in Houston, Texas
Christensen, P. A., Olsen, R. J., Long, S. W., Snehal, R., Davis, J. J., Ojeda Saavedra, M., Reppond, K., Shyer, M. N., Cambric, J., Gadd, R., Thakur, R. M., Batajoo, A., Mangham, R., Pena, S., Trinh, T., Kinskey, J. C., Williams, G., Olson, R., Golihar, J., Musser, J. M.
10.1101/2021.12.30.21268560 — Posted: 2022-01-01 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).